Cinacalcet is a calcimimetic medication used to manage secondary hyperparathyroidism in chronic kidney disease patients on dialysis and to treat hypercalcemia in parathyroid carcinoma. It works by increasing the sensitivity of calcium-sensing receptors in the parathyroid gland, reducing parathyroid hormone (PTH) secretion. This leads to lower calcium levels in the blood, helping prevent complications like bone disorders and cardiovascular issues.
Trusted Cinacalcet manufacturers in India ensure high-quality production, adhering to strict regulatory standards to meet global demand. With cost-effective and reliable supply chains, Indian manufacturers play a crucial role in making Cinacalcet accessible to patients worldwide. Effective calcium management with Cinacalcet improves patient outcomes and enhances quality of life.
